Home
About
Overview
Sharing Data
ORCID
Help
History (1)
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma.
OER-073: A multicenter phase 2 study evaluating the role of pazopanib in angiosarcoma. Cancer. 2022 10 01; 128(19):3516-3522.
View in:
PubMed
subject areas
Hemangiosarcoma
Humans
Indazoles
Pyrimidines
Receptors, Vascular Endothelial Growth Factor
Sulfonamides
Treatment Outcome
Vascular Endothelial Growth Factor A
authors with profiles
Andrew S Kraft